• CK2 and ERK8 Inhibitor: Illuminating Phase Separation Mechan

  2026-06-29

  Explore how the CK2 and ERK8 inhibitor, a potent small molecule inhibitor, advances understanding of kinase-driven phase separation in cell signaling. This article delivers in-depth analysis and practical assay guidance, setting a new benchmark for biochemical reagent use.

• Removing Pollen Spectral Interference in EEM Fluorescence Cl

  2026-06-29

  Zhang et al. present a machine learning and spectral transformation approach to eliminate pollen interference in excitation–emission matrix (EEM) fluorescence spectroscopy, dramatically improving classification accuracy for hazardous bioaerosols. This advance enables more reliable detection of toxins and pathogens in complex environmental samples, supporting public health monitoring.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Interactio

  2026-06-28

  This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, an alternative entry pathway independent of ACE2. These findings reveal a mechanistic bridge between the renin-angiotensin system and viral pathogenesis, suggesting new avenues for targeted research in both cardiovascular and infectious disease domains.

• Actinomycin D in Cancer Research: Protocols and Innovations

  2026-06-27

  Actinomycin D stands as a gold-standard transcriptional inhibitor for dissecting apoptosis induction and mRNA stability in cancer models. This article delivers actionable protocols, troubleshooting insights, and the latest evidence bridging epigenetic regulation to experimental design.

• Metronidazole: A Translational Lens on OAT3 Modulation & Mic

  2026-06-26

  Explore how Metronidazole, a nitroimidazole antibiotic and potent OAT3 inhibitor, bridges mechanistic insight with strategic opportunities in translational research. This thought-leadership piece integrates evidence-based guidance for optimizing transporter studies, microbiome-targeted interventions, and drug-drug interaction risk assessment, while situating Metronidazole within the evolving landscape of antimicrobial resistance solutions.

• CA-074 Me and the Future of Lysosomal Cell Death Research

  2026-06-26

  This thought-leadership article explores the transformative role of CA-074 Me, a selective and cell-permeable cathepsin B inhibitor, in advancing our mechanistic understanding and translational targeting of regulated cell death. By weaving together new mechanistic insights into necroptosis, strategic protocol guidance, and a critical analysis of the competitive research landscape, we offer translational scientists a roadmap to more impactful discoveries in apoptosis, inflammation, and liver injury models.

• ABT-888 (Veliparib): Enhancing DNA Repair Inhibition in Tumo

  2026-06-25

  ABT-888 (Veliparib) offers precision DNA repair inhibition, enabling robust chemo- and radiosensitization in challenging tumor models. This guide distills actionable workflows, troubleshooting tactics, and advanced applications for maximizing research impact with APExBIO's trusted ABT-888.

• Sulfur Transport Regulates Soybean Nodule Senescence via RNS

  2026-06-25

  This study uncovers a pivotal role for sulfur transport into the symbiosome in delaying soybean nodule senescence by sustaining glutathione levels and modulating reactive nitrogen species (RNS). These findings offer mechanistic insight into strategies for enhancing symbiotic nitrogen fixation and legume productivity.

• FOXM1 Inhibition by STL001: Sensitizing Cancers to Chemother

  2026-06-24

  A recent study introduces STL001 as a highly potent and selective FOXM1 inhibitor, capable of sensitizing a broad range of solid cancers to conventional therapies by overcoming drug resistance. This innovation offers a mechanistically targeted strategy to address treatment failure in cancers with high FOXM1 expression.

• BKT140 (BL-8040): Enabling Advanced CXCR4 Inhibition Workflo

  2026-06-23

  BKT140 (BL-8040) empowers researchers to dissect CXCR4-driven tumor biology and optimize stem cell mobilization with robust, reproducible results. Its exceptional solubility and validated performance make it the gold-standard antagonist for translational oncology and microenvironment-targeted studies.

• Ruxolitinib Phosphate (INCB018424): Applied JAK/STAT Pathway

  2026-06-23

  Ruxolitinib phosphate (INCB018424) is a precise tool for dissecting JAK/STAT signaling, making it indispensable in inflammatory and cancer research. This article translates the latest mechanistic insights and protocol strategies into actionable workflows for scientists tackling cytokine signaling and cell death pathways.

• nor-NOHA (acetate): Data-Driven Solutions for Cell-Based Ass

  2026-06-22

  This scenario-driven article provides evidence-based guidance on deploying nor-NOHA (acetate) (SKU C5407) for arginase inhibition workflows in cancer and endothelial research. Researchers will find actionable strategies to improve reproducibility, interpret results, and select high-purity inhibitors with confidence. The protocol and discussion leverage APExBIO’s nor-NOHA (acetate) as a reliable, data-backed reagent for demanding laboratory applications.

• Bafilomycin A1: Catalyzing Next-Gen Lysosomal and mRNA Resea

  2026-06-22

  Explore how Bafilomycin A1, a benchmark V-ATPase inhibitor, is redefining lysosomal function, intracellular pH regulation, and translational research—connecting mechanistic clarity with strategic guidance for those advancing mRNA delivery and disease modeling.

• Gemcitabine HCl: Optimizing MRI-Guided Pancreatic Cancer Res

  2026-06-21

  Gemcitabine HCl, a potent DNA synthesis inhibitor, is transforming high-throughput preclinical pancreatic cancer workflows, especially when paired with advanced multianimal MRI protocols. This article details applied experimental design, protocol enhancements, and troubleshooting strategies, helping researchers unlock reproducible, data-rich outcomes in tumor suppression and apoptosis induction studies.

• BCA Protein Assay Kit: Precision Bicinchoninic Acid Quantifi

  2026-06-20

  The BCA Protein Assay Kit empowers researchers to achieve highly sensitive, reproducible protein quantification in demanding workflows, such as blood–brain barrier pyroptosis studies. Its low sample requirements, robust linearity, and protocol flexibility deliver a clear advantage for molecular biology and neuroinflammatory research.

450 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page